Amgen, DxS, Roche deal

The partners will develop DxS' TheraScreen K-RAS Mutation Test as a companion diagnostic for Amgen's Vectibix panitumumab in the U.S. The test detects seven mutations in codons 12 and 13 of the K-Ra...